Unknown

Dataset Information

Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study.


ABSTRACT:

Background and purpose

The effects of direct oral anticoagulants in nonvalvular atrial fibrillation should be assessed in actual conditions of use. France has near-universal healthcare coverage with a unified healthcare information system, allowing large population-based analyses. NAXOS (Evaluation of Apixaban in Stroke and Systemic Embolism Prevention in Patients With Nonvalvular Atrial Fibrillation) aimed to compare the safety, effectiveness, and mortality of apixaban with vitamin K antagonists (VKAs), rivaroxaban, and dabigatran, in oral anticoagulant-naive patients with nonvalvular atrial fibrillation.

Methods

This was an observational study using French National Health System claims data and including all adults with nonvalvular atrial fibrillation who initiated oral an

SUBMITTER: Van Ganse E 

PROVIDER: S-EPMC7306262 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature